Stay updated on Pembrolizumab + Imprime PGG in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4. This appears to be a minor system revision that does not change the study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-10T10:47:15.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, representing a new revision of the page content.
    Difference
    0.0%
    Check dated 2026-07-27T05:43:14.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.3 instead of v3.6.2, indicating a new site revision tag. This is an administrative version update and does not modify the study data or available actions.
    Difference
    0.0%
    Check dated 2026-07-05T14:20:40.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2. This reflects a minor update to the page's underlying versioning, likely affecting the template or UI elements without altering the study content.
    Difference
    0.1%
    Check dated 2026-06-28T08:28:19.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    No textual changes are captured for this page in the provided dataset. The screenshots suggest a comparison, but no text changes are recorded in the change feed.
    Difference
    0.0%
    Check dated 2026-06-21T08:21:19.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    The study page now indicates that recruitment is closed to new participants, and adds navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a footer revision update (v3.6.0 replacing v3.5.5).
    Difference
    0.4%
    Check dated 2026-06-14T05:35:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Imprime PGG in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.